Argus analyst John Eade raised the firm’s price target on Cintas to $540 from $510 and keeps a Buy rating on the shares. The company is well positioned for the future as businesses increasingly prioritize employee health and workplace cleanliness, the analyst tells investors in a research note. Cintas balance sheet is clean and its management has signaled confidence in its outlook with a double-digit dividend hike, Argus added.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on CTAS: